| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0072 | 0.9 |